Dr. Stefanie Kesting appointed as CEO of Thyssengas
7.1.2026 13:27:37 CET | news aktuell GmbH | Press Release
Dortmund, 06.01.2026
As of January 1, 2026, Dr. Stefanie Kesting has been appointed as the new Chief Executive Officer (CEO) of Thyssengas GmbH. She succeeds Dr. Thomas Gößmann, who will retire at the end of February 2026 after nearly nine years at the helm of the company. The leadership transition was announced in autumn 2025.

Thyssengas is facing the biggest turning point in its history: in addition to natural gas, hydrogen and other green gases are to flow through the transmission network in increasing quantities in the future. The transmission system operator wants to lay the foundation for a new energy market. In this decisive phase, 49-year-old energy manager Dr. Stefanie Kesting is taking over the leadership of the company.
“In the coming years, it will be determined whether we succeed in the transformation and in establishing a new kind of resilience in energy supply. As a transmission system operator, we bear a special responsibility: We create the gas infrastructure that industry, SMEs, and regions need for their path toward a secure and climate-neutral future. At the same time, we bring our experience, our regional network, and our close ties to our western neighbours to actively shape this transition,” says Kesting. “Building the hydrogen core network is an important component, but it is only part of the picture. We need to think holistically: more regionally, across sectors, and always with a focus on what our customers and partners on the ground need for a secure energy supply and their individual decarbonization path. I am very much looking forward to driving this process forward together with the strong Thyssengas team.”
Dr. Stefanie Kesting has many years of leadership experience in the energy sector – including positions at international energy companies such as DNV, E.ON, and Uniper, and most recently at plant manufacturer Neuman & Esser, where she served as Managing Director responsible for the Energy Project Solutions business unit. Her professional focus has been on renewable gases, hydrogen, and CO₂ technologies for many years. In addition, she has served and continues to serve on several international supervisory boards in the energy and industrial sectors.
With the appointment of Dr. Stefanie Kesting, the Thyssengas management board will temporarily consist of:
- Dr. Stefanie Kesting, Chief Executive Officer
- Dr. Thomas Becker, Chief Financial Officer
- Dr. Thomas Gößmann, Member of the Management Board
As of March 1, 2026, the management board will comprise Dr. Stefanie Kesting (CEO) and Dr. Thomas Becker (CFO).

Contacts
Peter AlexewiczHead of Communications and Political AffairsThyssengas Gmb
Emil-Moog-Platz 13
44137 Dortmund
Images
About Thyssengas
Thyssengas GmbH is a German transmission system operator. The company, which celebrated its 100th anniversary in 2021, is headquartered in Dortmund. Thyssengas operates a gas network of approximately 4,400 kilometers – primarily in North Rhine-Westphalia, with some lines in Lower Saxony. Through this network, downstream distribution system operators as well as industrial companies and power plants are supplied. For a climate-neutral future, Thyssengas is focusing on hydrogen as a gaseous energy carrier. The Dortmund-based network operator is actively involved in numerous initiatives and is investing specifically in converting its pipeline system to enable a rapid hydrogen ramp-up as part of the energy transition. The company currently employs around 550 people at eight locations within its network area.

Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Compax MVNE continues to support Airalo’s eSIM platform2.3.2026 13:38:56 CET | Press Release
Vienna, March 2nd, 2026: Compax, a leading solution provider in the MVNO and telco space, will continue to support Airalo, the world’s first and largest eSIM platform.
Grünenthal takes full ownership of Grünenthal Meds, the joint venture established with Kyowa Kirin for its established medicines brands2.3.2026 10:07:51 CET | Press Release
Grünenthal acquired Kyowa Kirin International’s 49% stake in ‘Grünenthal Meds’, a joint venture formed in 2023 to market the established medicines portfolio from Kyowa Kirin International. Through this acquisition, Grünenthal assumes the sole responsibility of a portfolio comprising 12 brands across six therapeutic areas and >60 markets.
Valle Venia presents new song by LPS feat. Lara: Where will it take me27.2.2026 10:15:00 CET | Press Release
The song describes the challenge of trusting the flow, relying on oneself, following one's own values with confidence. In a time when everything seems to begin to dissolve, when disorientation prevails more than ever and when one is searching for something to hold on to, certainty can be found in uncertainty. Lara's authentic interpretation, with her multi-faceted voice, conveys confidence in finding a way for oneself and others. In the faceless, noisy crowd, where glances are not returned and touches are not felt, one is pulled away by an invisible hand. You are on your own, but somewhere there is a light and a hope that guides you when the fog lifts and you find yourself in the certainty of meeting someone who “can read my mind and my soul.” Invisibly connected, across time and space, this path is open.
Vyoma awarded ESA data procurement contract for space-based data on small space debris24.2.2026 10:57:08 CET | Press Release
Munich, February 24th, 2026 – Vyoma, a Munich-based company providing Space Domain Awareness (SDA) capabilities, has been selected as the winner of the ESA tender on ”Data Procurement for Space-Based Statistical Data on Small Space Debris Phase 1”, funded via ESA‘s Space Safety Programme (S2P).
Medi-Globe Launches mAI Companion® — the World’s First Real Time AI Assistant for Pancreatic EUS, Co Developed with IHU Strasbourg —Now MDR CE Marked and Available for Clinical Use in Europe24.2.2026 10:00:00 CET | Press Release
Rohrdorf (Achenmühle), Germany — February 24, 2026 — Medi-Globe today announced the launch of mAI Companion®, a real-time medical AI solution designed to assist physicians in detecting pancreatic lesions during endoscopic ultrasound (EUS) — addressing one of the deadliest and most difficult-to-detect cancers, where earlier identification can dramatically change patient outcomes.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom

